Latest Myopia News

CooperVision Expands Myopia Management & 1 Day Teams

June 7, 2021

SAN RAMON, Calif. — CooperVision has expanded its leadership on two of its teams: the Myopia Management team and the 1 Day team. Jennifer Lambert and Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA, have joined the Myopia Management sector of CooperVision as the Senior Global Brand Director and the Director of Global Professional Affairs, Myopia Management, respectively. Kamela Bearlin has joined the 1 Day Brands team as the Senior Global Brand Director.

“Myopia management and 1 Day represent our fastest-growing, highest-opportunity brands,” said Simon Seshadri, Senior Vice President, Global Marketing. “By investing in top talent, we’re moving forward at full speed to continuously grow our strong leadership and investment in these areas.”

Jennifer Lambert

As Senior Global Brand Director, Myopia Management, Jennifer Lambert works with CooperVision’s global and regional teams to expand its Brilliant Futures Myopia Management Program worldwide. This includes launching the program in markets where the lens alone is already available to support the best possible outcomes for age-appropriate* children with myopia. She will also advance a product roadmap that supports future growth in the myopia management category.

Lambert is based in Rochester, New York, and brings more than two decades of marketing experience from her most recent position as Vice President of Global Marketing at The HydraFacial Company and from past roles at Bausch + Lomb, Velocity Outdoor, PepsiCo, and Sun Products. Jennifer received her bachelor’s and master’s degrees in Advertising from The University of Illinois at Urbana-Champaign and an MBA from the University of Connecticut School of Business.

Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA

As Director of Global Professional Affairs, Myopia Management, Elizabeth Lumb works closely with CooperVision’s regional marketing and professional affairs teams to support the ongoing commercialization of the Brilliant Futures Myopia Management Program, including MiSight 1 day and the recently acquired SightGlass Vision technology.

Lumb is based in Manchester, United Kingdom. She has been part of the CooperVision team since 2015 and previously led MiSight 1 day’s rollout in Europe. Through key publications and conferences, Lumb has also driven heightened awareness of myopia management science. She is an optometrist with a first class honors degree from The University of Manchester and a Fellow of the British Contact Lens Association.

Kamela Bearlin

As Senior Global Brand Director, 1 Day brands, Kamela Bearlin works with regional commercial teams to grow the CooperVision wearer base and support market-leading growth through the company’s rapidly accelerating 1 Day silicone hydrogel portfolio. Building on the successes of the MyDay daily disposable and clariti 1 day families, Bearlin will also support continuous innovation on a global level.

Bearlin is based in Seattle, Washington, and brings over 15 years of global marketing experience with B2C and B2B2C brands, such as Philips Sonicare and Cadbury-Schweppes. Most recently, she spent eight years building her own marketing consultancy through which she built category knowledge with CooperVision as one of her clients. Bearlin holds a Bachelor of Science in Psychology from the University of Washington and completed a post-graduate Honors program at the University of Melbourne.

“We’re changing the game in the fight against the myopia epidemic with each new market that the Brilliant Futures program and MiSight 1 day contact lenses enter,” said Gary Orsborn, OD, MS, FAAO, FBCLA, Vice President, Global Professional, Medical and Clinical Affairs, CooperVision. “Our myopia management team’s latest additions fuel this momentum in advancing care for children with myopia worldwide.”

*U.S. Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

To Top